GMO Launches GMO Beyond China ETF (NYSE: BCHI) Focused on Global Supply Chain Shifts
MWN-AI** Summary
GMO, a prominent global investment manager, has recently launched the GMO Beyond China ETF (NYSE: BCHI), strategically designed to take advantage of the ongoing shifts in global supply chains away from China. This actively-managed ETF aims to provide investors with targeted exposure to a diversified portfolio of companies in various countries that are expected to benefit from this transition.
GMO's CEO, Scott Hayward, emphasized the importance of this launch, referring to it as part of the firm's commitment to innovative and accessible investment strategies. Analysts at GMO believe that the world is witnessing the onset of a multi-year or possibly multi-decade economic trend that could significantly reshape global manufacturing dynamics. This is not just about avoiding Chinese investments, but rather about identifying alternative opportunities in emerging market nations, particularly India, Mexico, and Vietnam, among others.
The ETF employs a three-step investment approach, beginning with a rigorous country selection process that leverages GMO’s extensive experience in emerging markets. Key considerations in country selection include demographics, cost competitiveness, and macroeconomic factors. Following country allocation, the strategy enhances sector and theme identification to locate areas likely to thrive from the supply chain realignment. The final step involves meticulous stock selection, focusing on high-quality companies with reasonable valuations.
With a potential portfolio of around 100 stocks, BCHI represents an expansion of GMO's ETF offerings, joining existing funds like GMO U.S. Quality and GMO International Value. The firm is also set to introduce more products in the near future, affirming its dedication to providing comprehensive investment solutions. Investors are encouraged to review the fund’s prospectus, highlighting the associated risks of investing in equities and non-U.S. markets.
MWN-AI** Analysis
As global supply chains continue to evolve, the launch of the GMO Beyond China ETF (NYSE: BCHI) presents a significant investment opportunity for those looking to capitalize on this transformative trend. Given the ongoing geopolitical tensions and economic shifts away from reliance on China, BCHI strategically focuses on emerging markets such as India, Mexico, and Vietnam. This is in line with a broader narrative that emphasizes the growth potential in countries set to benefit from global supply chain adjustments.
BCHI is particularly appealing due to GMO's expertise in top-down market allocation, bolstered by its quantitative and fundamental research approach. The fund aims to identify high-quality, reasonably valued companies, aiding investors in navigating the complexities of emerging markets. Moreover, sectors such as technology services, industrial real estate, and consumer goods are expected to thrive, facilitating long-term gains for investors.
While the potential for high returns exists, it is essential to acknowledge the associated risks. Investing in emerging markets entails market and non-U.S. investment risks, as these markets can exhibit greater volatility and lower liquidity than more established counterparts. Additionally, currency fluctuations can adversely affect investment outcomes, necessitating a careful review of market dynamics.
For investors looking to diversify their portfolios, BCHI offers an innovative response to shifting global economic landscapes. However, due diligence is crucial, including a thorough understanding of the fund's investment objectives, risks, and costs. As part of a broader investment strategy, consider how BCHI aligns with your financial goals and risk tolerance, keeping in mind the potential advantages of the long-term supply chain evolution and emerging market growth.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Fund focuses on identifying countries, sectors, and companies benefiting from secular changes.
GMO, a global investment manager known for its long-term, valuation-oriented strategies, today announced the launch of the GMO Beyond China ETF (NYSE: BCHI). This actively-managed ETF is designed to capitalize on the significant shift in global supply chains away from China, offering investors exposure to a carefully selected portfolio of companies that GMO believes are poised to benefit from this trend.
Building on the success of GMO's existing ETF lineup, BCHI represents a strategic expansion of the firm's investment solutions for a global investor base.
"The launch of the GMO Beyond China ETF is the latest example of our commitment to providing innovative, forward-looking investment strategies in accessible formats. This strategy intends to capture the substantial opportunities arising from the realignment of global manufacturing,” said Scott Hayward, Chief Executive Officer of GMO.
"We believe we are at the beginning of a multi-year, possibly multi-decade, trend that will reshape the global economy. This isn't just about avoiding China – it's about identifying the countries, sectors, and companies that are benefiting from this secular shift in global supply chains,” said Arjun Divecha, Founder of GMO Emerging Markets Equity.
"The GMO Beyond China ETF leverages our proprietary quantitative and fundamental methods to identify emerging market equities in countries like India, Mexico, and Vietnam that are well positioned for the dynamic changes ahead," said Warren Chiang, Portfolio Manager of BCHI.
The GMO Beyond China ETF combines GMO’s robust top-down approach to country allocation with thematic insights and bottom-up stock selection in a three-step investment approach.
- Country selection utilizing GMO's 30 years of expertise in top-down country allocation within emerging market equities, focusing on factors such as demographics, cost competitiveness, infrastructure, macroeconomics, trade momentum, and valuations.
- Sector and theme identification to target those which stand to benefit most from the shift away from China, including industrial real estate, technology services, consumer plays, and overarching themes like nearshoring, market share gains, and the global capex boom.
- Stock selection applying GMO's value discipline to identify high-quality companies at reasonable valuations within the selected countries and themes.
The GMO Beyond China ETF will hold a portfolio of up to about 100 stocks, focusing on countries such as Vietnam, Mexico, India, Thailand, and Indonesia, which are well-positioned to benefit from the ongoing supply chain shift.
The launch of BCHI further expands GMO’s lineup of ETFs, which includes GMO U.S. Quality (QLTY), GMO International Quality (QLTI), GMO U.S. Value (GMOV), and GMO International Value (GMOI). GMO also intends to launch GMO Systematic Investment Grade Credit (INVG) in the near future.
More information about GMO's ETFs can be found at: ETF Investing at GMO .
The GMO ETFs were launched with the support of the Goldman Sachs ETF Accelerator, a digital platform that enables Goldman Sachs’ clients to quickly and efficiently launch, list, and manage ETFs.
About GMO
Global investment manager GMO, established in 1977, brings together focused expertise within its investment teams, industry-leading research, and client solutions and service to advance clients' goals. Privately owned and renowned for conviction in a valuation-based, long-term investment philosophy, GMO serves sophisticated institutions, financial intermediaries, and families, and managed $65 billion as of December 31, 2024. The firm is headquartered in Boston, with offices in London, Sydney, Amsterdam, Singapore, and Tokyo (representative office). For more information, visit www.gmo.com .
Social Media:
LinkedIn: GMO
X: @GMOInsights
An investor should carefully consider the fund's investment objectives, risks, charges, and expenses before investing. This and other important information can be found in the fund's prospectus. To obtain a prospectus please visit www.gmo.com . Read the prospectus carefully before investing.
Risks associated with investing in the Fund may include: (1) Market Risk - Equities: The market price of equities may decline due to factors affecting the issuer, its industries, or the economy and equity markets generally. Declines in stock market prices generally are likely to reduce the net asset value of the Fund's shares. (2) Non-U.S. Investment Risk: The market prices of many non-U.S. securities (particularly of companies tied economically to emerging countries) fluctuate more than those of U.S. securities. Many non-U.S. markets (particularly emerging markets) are less stable, smaller, less liquid, and less regulated than U.S. markets, and the cost of trading in those markets often is higher than it is in U.S. markets. (3) Currency Risk: Fluctuations in exchange rates can adversely affect the market value of the Fund's non-U.S. currency holdings and investments denominated in non-U.S. currencies. For a more complete discussion of these risks and others, please consult the Fund's Prospectus.
The GMO ETFs are distributed in the United States by Foreside Fund Services LLC. GMO and Foreside Fund Services LLC are not affiliated.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250212782994/en/
Media Contact:
Steve Schaefer
Hewes Communications, Inc.
212-207-9456
steve@hewescomm.com
FAQ**
How does the investment strategy of the GMO Beyond China ETF (BCHI) compare to that of the GMO International Quality ETF QLTI in terms of country allocation and sector focus?
What specific countries, sectors, and themes does the GMO Beyond China ETF target, and how do they differ from those within the GMO International Quality ETF QLTI’s portfolio?
Can you explain the methodology used for stock selection in the GMO Beyond China ETF and how it contrasts with the stock selection approach of GMO International Quality ETF QLTI?
Given the risks mentioned, such as market and currency risks, how does the risk profile of the GMO Beyond China ETF (BCHI) compare to that of the GMO International Quality ETF QLTI?
**MWN-AI FAQ is based on asking OpenAI questions about GMO US Value ETF (NYSE: GMOV).
NASDAQ: GMOV
GMOV Trading
-0.61% G/L:
$30.27 Last:
6,963 Volume:
$30.39 Open:
